verified COP 2,7 · Q2 • database Scopus / SJR & Web of Science indexed

United Arab Emirates · Bentham Science Publishers

workspace_premium Q2 — Pharmacology lock Subscription

Current Pharmaceutical Design

Current Pharmaceutical Design is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 190. It has a COP Index of 2,7 (best band Q2). It is published in English. It has a COP Index of 2,7.

Current Pharmaceutical Design focuses its scope in these topics and keywords: systematic, current, arterial, reviewthe, erectile, modeling, management, pharmacological, atherosclerosis, reviewinsilico, ...

ISSN: 1381-6128

Publisher: Bentham Science Publishers

Category: Drug Discovery

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

COP Index trending_up

2,7 Q2

138 of 284 journals in Pharmacology

H-index · SJR 190 · 0,611

Acceptance rate pie_chart

21% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

COP Index

2,7

SJR Impact

0,611

H-index

190

Docs (year)

260

Docs 3y

1077

Total refs

21803

Cites 3y

2955

Citable 3y

981

Cites/Doc 2y

2.61

Ref/Doc

83.86

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Antithrombotic therapy in patients with recent stroke and atrial fibrillation

Vitex Diterpenoids: Structural Diversity and Pharmacological Activity

Copper and Neurotoxicity in Autism Spectrum Disorder

Comprehensive Essential Gene Identification as a Platform for Novel Antiinfective Drug Discovery

Citrus species: A Review of Traditional Uses, Phytochemistry and Pharmacology

Cisplatin Toxicology: The Role of Pro-inflammatory Cytokines and GABA Transporters in Cochlear Spiral Ganglion

Circulating miRNAs in Successful and Unsuccessful Aging. A Mini-review

Circadian-Hypoxia Link and its Potential for Treatment of Cardiovascular Disease

Chemotherapy of Leishmaniasis

Cellular and Molecular Mechanisms of Antithrombogenic Plants: A Narrative Review

beta-lactam Resistance in Gram-negative Pathogens Isolated from Animals

Basic Cell Biology of Trypanosoma cruzi

SHOW MORE ARTICLES

Antithrombotic treatment after atrial fibrillation ablation

A Mechanistic Approach to Anticancer Therapy: Targeting the Cell Cycle with Histone Deacetylase Inhibitors

Antiatherosclerotic and Cardioprotective Effects of Time-Released Garlic Powder Pills

Anti-NMDA Receptor Encephalitis, Vaccination and Virus

An Overview of Bioinformatics Methods for Analyzing Autism Spectrum Disorders

Ajmalicine and its Analogues against AChE and BuChE for the Management of Alzheimer's Disease: An In-silico study

Adjunctive Immunotherapy of Mycobacterial Infections

Activation of Melanocortin-4 Receptor by a Synthetic Agonist Inhibits Ethanolinduced Neuroinflammation in Rats

Action of Anti-HIV Drugs and Resistance: Reverse Transcriptase Inhibitors and Protease Inhibitors

A Spectrum of Topics for 2019: Advances in Neuroinflammation, Oxidative Stress, Obesity, Diabetes Mellitus, Cardiovascular Disease, Autism, Exosomes, and Central Nervous System Diseases

A Review on the Phytochemistry, Ethnobotanical Uses and Pharmacology of Borago Species

A Pooled Analysis of the Prognostic Significance of Brugada Syndrome with Atrial Fibrillation

FAQs

Current Pharmaceutical Design has a COP Index of 2,7 (Q2), ranked 138 of 284 in Pharmacology. SJR: 0,611.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Current Pharmaceutical Design is 21%.

Current Pharmaceutical Design

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the COP Index of Current Pharmaceutical Design?

What is the APC / publication cost?

What is the acceptance rate?